Latest News and Press Releases
Want to stay updated on the latest news?
-
VALENCIA, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today reported with deep sadness the passing of Alfred E. Mann, age 90, the company’s Chairman...
-
VALENCIA, Calif., Feb. 19, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that on February 17, 2016 MannKind received notice from Alfred E. Mann that he...
-
VALENCIA, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), focused on the discovery and development of therapeutic products for diabetes, announced today...
-
VALENCIA, Calif., Jan. 27, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will host a conference call to discuss Company developments at 5:00 PM (Eastern Time) on...
-
VALENCIA, Calif., Jan. 21, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today announced that it has entered into a collaboration and license agreement with a newly...
-
VALENCIA, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that MannKind has withdrawn its offer to employ Duane M. DeSisto as its President...
-
VALENCIA, Calif., Jan. 05, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today announced the termination of its license and collaboration agreement with sanofi-aventis...
-
ולנסיה, קליפורניה, Dec. 29, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) ו-(TASE:MNKD), שמתמקדת בגילוי ופיתוח של מוצרים טיפוליים לסוכרת, הודיעה היום שתציג מצגת בכנס הבריאות השנתי...
-
VALENCIA, Calif., Dec. 29, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), focused on the discovery and development of therapeutic products for diabetes, announced today...
-
VALENCIA, Calif., Dec. 23, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) and (TASE:MNKD) today announced the appointment of Duane M. DeSisto as its President and Chief Executive...